Sam Altman, AI and Retro Biosciences

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.
Sam Altman-backed start-up is raising $1B to extend human lifespan
OpenAI CEO Sam Altman backs Retro Biosciences, a San Francisco-based biotech start-up that wants to extend human lifespan by 10 years beyond what it describes as a healthy lifespan. The company is now raising $1 billion in a Series A funding round, with Altman participating.
With Sam Alt­man’s help, Retro Bio­sciences eyes $1B to ex­tend lifes­pan by 10 years
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed in a Friday email to Endpoints News.
The Prototype: OpenAI And Retro Biosciences Made An AI Model For Bioengineering
Plus: Blue Origin and SpaceX launch big rockets, how magnets could guide lasers to make better computers, how to best work ...
The ChatGPT AI model nobody talks about might add years to your life
OpenAI has created a ChatGPT model called GPT-4b micro for Retro Biosciences, a longevity research company - here's what it ...
AI tracker: AI at the Maha Kumbh, and in longevity science
We saw several innovative uses of AI in the past week, and a bad slip-up in news sharing. A quick round-up: ...
MIT Technology Review9d
OpenAI has created an AI model for longevity science
OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their ...
Sam Altman-Backed Retro Biosciences Raising $1 Billion to Extend Human Lifespan
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...